Guaifenesin

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Guaifenesin
Generic name
GUAIFENESIN 400 MG
Manufacturer
Zennova LLC
Product type
HUMAN OTC DRUG
SPL set ID
52f5cda7-382e-199a-e063-6294a90ab75b
SPL ID
5dcf0b44-f146-e929-e063-6394a90a345d
Version
3
Effective date
2026-10-14
Source export date
2026-11-13
Source partition
2
Source file
https://download.open.fda.gov/drug/label/drug-label-0002-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-13/3b4204ed830f35b16ab24b2123672d7d93066eb0fd8af1cf09b223d0e4568221/drug-label-0002-of-0014.json.zip
Source manifest SHA-256
8f2b6d063d44586cf97cedcdf1bdf9e261cc88632cc6855424b801bb206208d7
Import run
20261116T150851Z
Imported at
2026-11-16 15:31:41
Harmonized routes table
Harmonized routes
ORAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings A persistent cough maybe a sign of a serious condition. If cough persists for more than 1 week, tends to recur, or is accompanied by a fever, rash or persistent headache, consult a doctor. Do not use - For children under 12 years of age ASK A DOCTOR BEFORE USE IF YOU HAVE Persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis or emphysema. Cough accompanied by too much phlegm (mucus). STOP USE AND ASK A DOCTOR IF if cough lasts more than 7 days, please consult your physician or healthcare provider. When using this product Do not exceed recommended dosage. Do not consume alcohol, benzodiazepines or opioids. KEEP OUT OF REACH OF CHILDREN In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away. IF PREGNANT OR BREAST-FEEDING ask a health professional before use

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.